Related Experiment Videos

Hypertension, blood pressure, and heart rate variability: the Atherosclerosis Risk in Communities (ARIC) study

Emily B Schroeder1, Duanping Liao, Lloyd E Chambless

  • 1Department of Epidemiology, School of Public Health, University of North Carolina, 137 E Franklin St, Ste 306, Chapel Hill, NC 27514, USA.

Insights

Low heart rate variability (HRV) predicts a higher risk of developing hypertension. While individuals with hypertension show decreased HRV, the autonomic nervous system

Area of Science:

  • Cardiovascular physiology
  • Autonomic nervous system function
  • Hypertension research

Background:

  • Autonomic nervous system (ANS) dysregulation is linked to hypertension development.
  • Heart rate variability (HRV) quantifies cardiac autonomic activity and is reduced in hypertensive individuals.
  • The predictive value of low HRV for incident hypertension and hypertension's effect on HRV requires further investigation.

Purpose of the Study:

  • To investigate the temporal relationship between hypertension, blood pressure, and HRV.
  • To determine if low HRV predicts future hypertension.
  • To assess if hypertension influences HRV changes over time.

Main Methods:

  • Population-based cohort study of 11,061 individuals aged 45-54 years at baseline.
  • Analysis of baseline blood pressure and HRV parameters (SDNN, RMSSD, RR interval).
  • Longitudinal follow-up over 9 years to assess incident hypertension and changes in HRV.

Main Results:

  • Individuals with hypertension exhibited decreased HRV at baseline across the blood pressure spectrum.
  • Low HRV at baseline predicted a significantly greater risk of developing hypertension over 9 years (HR 1.24-1.44).
  • No significant difference in the rate of HRV change was observed between hypertensive and normotensive groups over time.

Conclusions:

  • Findings support the role of the autonomic nervous system in hypertension development.
  • Low HRV is a predictor of incident hypertension.
  • Autonomic profiles of hypertensive and normotensive individuals do not diverge significantly over time.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...